ULVAC, Inc. (TYO:6728)

Market Cap	273.00B
Revenue (ttm)	263.63B
Net Income (ttm)	20.05B
Shares Out	49.24M
EPS (ttm)	406.94
PE Ratio	13.62
Forward PE	14.46
Dividend	164.00 (2.96%)
Ex-Dividend Date	Jun 27, 2025

Volume	566,900
Average Volume	409,550
Open	5,507.00
Previous Close	5,607.00
Day's Range	5,403.00 - 5,580.00
52-Week Range	3,915.00 - 9,543.00
Beta	1.03
RSI	60.23
Earnings Date	Aug 13, 2025

About Intra-Cellular Therapies

ULVAC, Inc. engages in vacuum equipment and applications business in Japan and internationally. It offers FPD manufacturing equipment, which includes sputtering, plasma CVD, organic EL manufacturing, roll-type vacuum evaporation, vacuum evaporation, roll-up sputtering equipment, and other equipment; and semiconductor and electronic component manufacturing equipment including etching, ion implantation, ashing, wafer pre-treatment, ultra-high vacuum equipment, etc. The company also provides various vacuum pumps, such as dry, oil rotary, mechanica...

• Industry: Hardware, Equipment & Parts
• Sector: Technology
• Founded: 1929
• Employees: 6,234
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6728

Financial Performance

In 2024, ULVAC's revenue was 261.12 billion, an increase of 14.76% compared to the previous year's 227.53 billion. Earnings were 20.23 billion, an increase of 42.80%.